Financial Ratios Monash IVF Group Limited
Equities
MVF
AU000000MVF3
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7375 AUD | -1.01% |
|
0.00% | -42.13% |
03/07 | Monash IVF Group Discloses Interim Remuneration Package for Acting CEO | MT |
13/06 | Monash IVF Says Challenger Ceases to Be a Substantial Holder | MT |
Fiscal Period: June | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.38 | 6.07 | 4.85 | 5.45 | 5.36 | |||||
Return on Total Capital | 4.88 | 6.81 | 5.36 | 6.06 | 6.59 | |||||
Return On Equity % | 5.53 | 9.79 | 6.87 | 8.06 | -2.28 | |||||
Return on Common Equity | 5.54 | 9.74 | 6.89 | 8.07 | -2.53 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.02 | 36.16 | 34.57 | 34.1 | 33.6 | |||||
SG&A Margin | 8.45 | 7.79 | 9.57 | 8.53 | 8.09 | |||||
EBITDA Margin % | 17.77 | 20.81 | 17.22 | 18.92 | 18.25 | |||||
EBITA Margin % | 15.38 | 18.52 | 14.75 | 16.38 | 15.64 | |||||
EBIT Margin % | 15.38 | 18.52 | 14.75 | 16.38 | 15.64 | |||||
Income From Continuing Operations Margin % | 8.09 | 13.89 | 9.62 | 10.28 | -2.33 | |||||
Net Income Margin % | 8.06 | 13.7 | 9.57 | 10.22 | -2.56 | |||||
Net Avail. For Common Margin % | 8.06 | 13.7 | 9.57 | 10.22 | -2.56 | |||||
Normalized Net Income Margin | 7.14 | 10.55 | 8.47 | 9.22 | 8.25 | |||||
Levered Free Cash Flow Margin | 14.5 | 12.5 | 6.82 | 6.01 | 26.42 | |||||
Unlevered Free Cash Flow Margin | 16.95 | 13.15 | 7.49 | 6.89 | 27.59 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.46 | 0.52 | 0.53 | 0.53 | 0.55 | |||||
Fixed Assets Turnover | 4.03 | 2.99 | 2.37 | 2.09 | 2.06 | |||||
Receivables Turnover (Average Receivables) | 46.95 | 48.1 | 45.68 | 45.79 | 38.64 | |||||
Inventory Turnover (Average Inventory) | 23.83 | 28.71 | 26.57 | 24.09 | 23.2 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.81 | 0.55 | 0.67 | 0.64 | 0.47 | |||||
Quick Ratio | 0.63 | 0.37 | 0.43 | 0.4 | 0.35 | |||||
Operating Cash Flow to Current Liabilities | 0.82 | 1.07 | 0.84 | 0.84 | 0.44 | |||||
Days Sales Outstanding (Average Receivables) | 7.79 | 7.59 | 7.99 | 7.97 | 9.47 | |||||
Days Outstanding Inventory (Average Inventory) | 15.36 | 12.71 | 13.74 | 15.15 | 15.77 | |||||
Average Days Payable Outstanding | 14.36 | 8.19 | 8.04 | 6.68 | 5.27 | |||||
Cash Conversion Cycle (Average Days) | 8.8 | 12.12 | 13.69 | 16.44 | 19.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 22.84 | 17.1 | 28.62 | 36.37 | 54.88 | |||||
Total Debt / Total Capital | 18.59 | 14.6 | 22.25 | 26.67 | 35.43 | |||||
LT Debt/Equity | 21.92 | 14.32 | 25.97 | 34.07 | 51.64 | |||||
Long-Term Debt / Total Capital | 17.84 | 12.23 | 20.19 | 24.98 | 33.34 | |||||
Total Liabilities / Total Assets | 27.76 | 23.42 | 29.13 | 34.8 | 51.49 | |||||
EBIT / Interest Expense | 3.91 | 13.87 | 13.19 | 10.59 | 7.44 | |||||
EBITDA / Interest Expense | 5.51 | 18.24 | 18.93 | 14.49 | 10.49 | |||||
(EBITDA - Capex) / Interest Expense | 4.19 | 14.14 | 13.46 | 6.08 | 6.61 | |||||
Total Debt / EBITDA | 1.83 | 1.03 | 1.9 | 2.09 | 2.4 | |||||
Net Debt / EBITDA | 1.35 | 0.83 | 1.7 | 1.92 | 2.2 | |||||
Total Debt / (EBITDA - Capex) | 2.4 | 1.33 | 2.67 | 4.98 | 3.82 | |||||
Net Debt / (EBITDA - Capex) | 1.77 | 1.07 | 2.39 | 4.58 | 3.5 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -4.32 | 26.26 | 4.73 | 11.07 | 19.38 | |||||
Gross Profit, 1 Yr. Growth % | -3.65 | 30.38 | 0.13 | 9.55 | 17.43 | |||||
EBITDA, 1 Yr. Growth % | -29.12 | 47.9 | -12.38 | 21.99 | 15.31 | |||||
EBITA, 1 Yr. Growth % | -31.67 | 52.02 | -15.55 | 23.36 | 14.06 | |||||
EBIT, 1 Yr. Growth % | -31.67 | 52.02 | -15.55 | 23.36 | 14.06 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -40.63 | 116.88 | -27.97 | 18.72 | -127.08 | |||||
Net Income, 1 Yr. Growth % | -40.93 | 114.46 | -27.34 | 18.65 | -129.89 | |||||
Normalized Net Income, 1 Yr. Growth % | -42.75 | 86.56 | -14.73 | 20.89 | 6.87 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -46.43 | 42.23 | -27.69 | 19.15 | -130.36 | |||||
Accounts Receivable, 1 Yr. Growth % | 24.58 | 22.21 | 0.52 | 21.01 | 20.46 | |||||
Inventory, 1 Yr. Growth % | -0.85 | 6.79 | 24.59 | 22.38 | 27.18 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 236.65 | 20.97 | 41.27 | 15.07 | 26.26 | |||||
Total Assets, 1 Yr. Growth % | 20.34 | 0.61 | 8.66 | 10.79 | 20.52 | |||||
Tangible Book Value, 1 Yr. Growth % | -85.27 | -154.24 | 30.54 | -180.35 | 664.31 | |||||
Common Equity, 1 Yr. Growth % | 44.22 | 6.75 | 0.65 | 1.97 | -11.46 | |||||
Cash From Operations, 1 Yr. Growth % | -6.09 | 41.75 | -27.49 | 22.68 | 34.24 | |||||
Capital Expenditures, 1 Yr. Growth % | 14.86 | 33.65 | 18.13 | 136.24 | -19.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 3.82 | 7.3 | -41.53 | -2.13 | 423.25 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 8.68 | -2.06 | -39.01 | 2.08 | 377.06 | |||||
Dividend Per Share, 1 Yr. Growth % | -65 | 100 | 4.76 | 0 | 13.64 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.75 | 9.91 | 14.99 | 7.86 | 15.21 | |||||
Gross Profit, 2 Yr. CAGR % | -7.83 | 12.08 | 14.26 | 4.73 | 13.58 | |||||
EBITDA, 2 Yr. CAGR % | -16.49 | 2.39 | 13.21 | 3.39 | 18.61 | |||||
EBITA, 2 Yr. CAGR % | -17.86 | 1.92 | 12.61 | 2.07 | 18.62 | |||||
EBIT, 2 Yr. CAGR % | -17.86 | 1.92 | 12.61 | 2.07 | 18.62 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -25.49 | 13.48 | 25.43 | -7.53 | -43.3 | |||||
Net Income, 2 Yr. CAGR % | -25.9 | 12.55 | 25.29 | -7.15 | -40.45 | |||||
Normalized Net Income, 2 Yr. CAGR % | -25.44 | 3.35 | 25.28 | 1.53 | 13.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -29.57 | -12.71 | 2.2 | -7.18 | -39.86 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.38 | 23.39 | 10.84 | 10.29 | 30.7 | |||||
Inventory, 2 Yr. CAGR % | 1.22 | 2.9 | 15.35 | 23.48 | 24.76 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 81.24 | 101.8 | 30.73 | 27.5 | 20.53 | |||||
Total Assets, 2 Yr. CAGR % | 9.59 | 10.04 | 4.45 | 9.72 | 15.55 | |||||
Tangible Book Value, 2 Yr. CAGR % | -62.85 | -71.74 | -14.54 | 2.42 | 147.82 | |||||
Common Equity, 2 Yr. CAGR % | 22.45 | 24.08 | 3.56 | 1.31 | -4.98 | |||||
Cash From Operations, 2 Yr. CAGR % | 9.48 | 15.38 | 1.29 | -5.68 | 28.33 | |||||
Capital Expenditures, 2 Yr. CAGR % | 6.98 | 23.9 | 25.18 | 67.05 | 33.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 29.5 | 6.33 | -21.69 | -24.35 | 126.73 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 29.42 | 3.17 | -23.55 | -21.1 | 121.04 | |||||
Dividend Per Share, 2 Yr. CAGR % | -40.84 | -16.33 | 44.75 | 2.35 | 6.6 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.14 | 6.82 | 8.16 | 13.67 | 11.6 | |||||
Gross Profit, 3 Yr. CAGR % | -9.38 | 3.47 | 7.95 | 12.67 | 8.91 | |||||
EBITDA, 3 Yr. CAGR % | -18.78 | 1.04 | -3.15 | 16.07 | 7.22 | |||||
EBITA, 3 Yr. CAGR % | -20.55 | 0.85 | -4.67 | 16.08 | 5.92 | |||||
EBIT, 3 Yr. CAGR % | -20.55 | 0.85 | -4.67 | 16.08 | 5.92 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -26.5 | 6.39 | -2.25 | 23.15 | -38.59 | |||||
Net Income, 3 Yr. CAGR % | -26.57 | 5.6 | -2.49 | 23.03 | -36.37 | |||||
Normalized Net Income, 3 Yr. CAGR % | -26.1 | 1.22 | -3.5 | 23.8 | 3.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -28.86 | -10.98 | -17.6 | 7.56 | -36.05 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.2 | 9.31 | 15.24 | 14.13 | 19.75 | |||||
Inventory, 3 Yr. CAGR % | 5.09 | 3.05 | 9.67 | 17.65 | 24.7 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 49.19 | 58.39 | 79.19 | 25.28 | 27.08 | |||||
Total Assets, 3 Yr. CAGR % | 6.71 | 6.51 | 9.5 | 6.52 | 13.21 | |||||
Tangible Book Value, 3 Yr. CAGR % | -48.63 | -57.85 | -52.44 | -16.28 | 100.14 | |||||
Common Equity, 3 Yr. CAGR % | 15.17 | 16.98 | 15.65 | 3.03 | -3.14 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.25 | 19.32 | -1.23 | 7.97 | 6.09 | |||||
Capital Expenditures, 3 Yr. CAGR % | 4.37 | 15.22 | 21.64 | 54.69 | 27.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 24.98 | 22.23 | -13.55 | -15.65 | 44.32 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 24.2 | 17.94 | -14.04 | -15.82 | 43.9 | |||||
Dividend Per Share, 3 Yr. CAGR % | -37.97 | -11.21 | -9.82 | 27.96 | 5.98 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.08 | 3.24 | 4.38 | 7.23 | 10.92 | |||||
Gross Profit, 5 Yr. CAGR % | -0.64 | -0.88 | -0.57 | 3.97 | 10.17 | |||||
EBITDA, 5 Yr. CAGR % | -8.8 | -4.88 | -7.24 | 1.75 | 5.03 | |||||
EBITA, 5 Yr. CAGR % | -10 | -5.6 | -8.66 | 1.09 | 4.04 | |||||
EBIT, 5 Yr. CAGR % | -10 | -5.6 | -8.66 | 1.09 | 4.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -11.26 | -2.38 | -8.98 | 0.73 | -21.38 | |||||
Net Income, 5 Yr. CAGR % | -11.31 | -2.66 | -9.08 | 0.45 | -19.95 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.92 | -5.26 | -8.73 | 1.07 | 3.03 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -13.33 | -12.1 | -17.77 | -9.2 | -27.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.5 | 5.2 | 2.82 | 9.7 | 21.19 | |||||
Inventory, 5 Yr. CAGR % | - | - | 9.08 | 10.78 | 15.47 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 30.91 | 34.58 | 41.51 | 45.22 | 52.91 | |||||
Total Assets, 5 Yr. CAGR % | 4.28 | 4.08 | 5.8 | 7.74 | 11.88 | |||||
Tangible Book Value, 5 Yr. CAGR % | -35.04 | -41.65 | -37.03 | -39.51 | -7.96 | |||||
Common Equity, 5 Yr. CAGR % | 11.64 | 11.48 | 10.38 | 10.4 | 6.91 | |||||
Cash From Operations, 5 Yr. CAGR % | -2.9 | -0.05 | 4.24 | 8.57 | 9.68 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.32 | 4.11 | 12.24 | 33.48 | 26.08 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -3.08 | -0.9 | 3.97 | 0.42 | 27.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -2.09 | -1.97 | 2.29 | -0.01 | 25.42 | |||||
Dividend Per Share, 5 Yr. CAGR % | -21.29 | -13.15 | -12.94 | -6.01 | -3.58 |
- Stock Market
- Equities
- MVF Stock
- Financials Monash IVF Group Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition